Back
ROIV
Roivant Sciences Ltd.
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 3.37%
Annual Growth
5 years average annual capital growth
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Roivant Sciences Ltd. is a biopharmaceutical company focused on improving the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
📈 Performance
Price History*
+15.72%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$11.55
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ROIV
3
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
30 weeks
💵 Average investment amount
$365
⏰ Last time a customer invested in ROIV
205 days
ROIV investor breakdown
💵 Income of investors
More than 200k
33%
150k - 200k
33%
100k - 150k
50k - 100k
Less than 50k
33%
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in ROIV also invest in...
🙌 Performance (5Yr p.a)
302.84%
📊 Share price
$180.77 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
11.78%
📊 Share price
$110.28 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
2.48%
📊 Share price
$42.89 USD
Want more shares? Try these...
🙌 Performance (5Yr p.a)
9.74%
📊 Share price
$332.59 USD
📈 HIGH PRICE GROWTH
